All In Biotech

Free tool

FAERS Monitor: Leqembi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761269 or its brand name (Leqembi, Lecanemab-Irmb). Reports on generic versions are filed under their own applications.

Reports

3,813

Serious

1,660

44% of reports

Hospitalization

970

Death reported

164

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • amyloid related imaging abnormality-oedema/effusion530
  • headache492
  • amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits487
  • infusion related reaction330
  • chills249
  • fatigue225
  • pyrexia179
  • dizziness175
  • confusional state172
  • nausea156
  • cerebral haemorrhage136
  • fall118
  • amyloid related imaging abnormalities99
  • cerebral infarction98
  • vomiting95

Reports by year received

View as table
YearReports
20211
20227
2023263
20241,402
20251,364
2026776

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,346 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
amyloid related imaging abnormality-microhaemorrhages and haemosiderin depositsSignal4874588.04085.91,217,281
amyloid related imaging abnormality-oedema/effusionSignal5304179.93750.91,257,872
amyloid related imaging abnormalitiesSignal992495.61972.5168,304
infusion related reactionSignal33027.624.98,416
cerebral infarctionSignal9822.218.31,958
cerebral haemorrhageSignal13621.017.82,569
chillsSignal24911.710.42,444
confusional stateSignal1725.95.1696
headacheSignal4924.34.01,295
pyrexiaSignal1792.92.5217
fall1182.01.655
dizziness1751.91.780
fatigue2251.61.451
vomiting951.10.91
nausea1561.10.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.